DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Ronot M, Bouattour M, Wassermann J. , et al.
Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib.
Oncologist 2014;
19 (04) 394-402
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.